I’ve been seeing more compounded peptides offered with additives like B12, Zinc, L-Carnitine, etc. often positioned as ‘enhanced’ formulas for mitigating side effects or boosting efficacy. To steel-man the case for adding B12 to something like semaglutide: the mechanism is plausible. GLP-1s can impact nutrient absorption, and B12 is a critical cofactor in energy metabolism. So, the theory is that adding it back in prevents the fatigue some users report. It sounds logical on a whiteboard. But mechanism and outcome are different claims. The real question is, does this bundled approach produce a better result than the base peptide alone? We’re taking two separate interventions, bundling them into one injection, and then attributing any positive result to the combination. This makes it impossible to know what’s actually doing the work. If someone feels less fatigue on a tirzepatide + B12 blend, how can we distinguish between these possibilities? 1. The tirzepatide is working as expected. 2. 😂 The person was B12 deficient to begin with, and any form of supplementation would have helped. 3. Placebo effect from using a more expensive, ‘premium’ product. Without a control, it’s just a guess. We’re paying a premium for a variable we can’t isolate. Three things would update my thinking on this: First, any comparative data, even an informal group analysis, tracking subjective side effects (e.g., fatigue scores) between a cohort on a base formula and one on a combo formula. Second, a clear biochemical argument for why co
your point about needing to isolate variables holds up, especially with what you’re calling the ‘premium’ formulas. For those of us post-bariatric, B12 deficiency is a known variable, and it’s why I
1 Like